InCROM Subsidiary in Shanghai Set to Become Subsidiary of Chinese Pharma Giant, Aims for Business Expansion

Jinjiro Kanada, President, InCROM Inc. Japan’s InCROM Inc., a clinical research organization, and its subsidiary in Shanghai agreed last month to turn the subsidiary into a joint venture, accepting a capital injection from state-run China National Pharmaceutical Group Corp. “There...read more